In a research report released this morning, Maxim Group analyst Jason Kolbert reiterated a Buy rating on Cytori Therapeutics Inc (NASDAQ:CYTX) with a price target …
Roth Capital’s healthcare analyst Joseph Pantginis weighed in with a few insights on Cytori Therapeutics Inc (NASDAQ:CYTX), as the company announced that the first patient has been …
